Chaired by: Professor Beverley Hunt OBE(a) Where are we going to improve quality and safety of imaging for VTE? - Dr Narayan Karunanithy(b) Will we ever develop a perfect anticoagulant? - Professor Helen Philippou(c) Improving VTE risk assessment for thromboprophylaxis in UK hospitals - Professor Roopen Arya

Chaired by: Professor Roopen AryaGIRFT findings - Dr Lara RobertsLocal impact and changes implemented as a result of GIRFT - Andrew GillettPanel discussion and Q&A session - Dr Lara Roberts, Emma Gee, Rebecca Simpson, Andrew Gillett

Chaired by: Professor Beverley Hunt OBESpeakers: Dr Josie Jenkinson, Dr Thomas York, Dr Ashma Mohamed, Dr Michael Cheah

In this tutorial, Beverley introduces vaccine-induced immune thrombocytopenia and thrombosis syndrome, an extremely rare immune response to a vaccine causing thrombosis (blood clots) and thrombocytopenia (low platelet count), most commonly following the Astra-Zeneca vaccine.

In this tutorial, Beverley discussed blood clots in acute COVID-19 infection, including who is at risk, the types of thrombosis seen, and what preventative measures are recommended for moderately and severely unwell patients.

In this tutorial, Beverley outlines the risk of thrombosis in Long COVID, including what we know so far about thrombosis risk, seated immobility syndrome which does increase risk of blood clots, and what, if anything, does a D-dimer test tell us about someone’s risk of blood clots.

Becs Walsh, Lead Pharmacist for Anticoagulation & Thrombosis Prevention, Sheffield Teaching Hospital NHS Foundation Trust

Susie Shapiro, Haematology Consultant at Oxford University Hospitals

 Huw Rowswell, Nurse consultant in Thrombosis, University Hospitals Plymouth

Carol Law and Rebecca Locke, VTE Education Specialists